Liver transplantation: Boceprevir increases levels of ciclosporin and tacrolimus

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 7, 2012, Pages 366-

  McLarnon, Andy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; CYCLOSPORIN A; DRUG METABOLITE; TACROLIMUS;

DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; GRAFT RECIPIENT; GRAFT REJECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER TRANSPLANTATION; MASS SPECTROMETRY; NOTE; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 84863431452     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.110     Document Type: Note

References (1)

1. Hulskotte, E. et al. Pharmacokinetic interaction between the HCV protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers. Hepatology doi:10.1002/hep.25831